Published in Dig Dis Sci on April 12, 2008
Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV. Hepat Mon (2011) 0.96
Correlation between hepatitis B surface antigen titers and HBV DNA levels. Saudi J Gastroenterol (2013) 0.96
Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation. Dig Dis Sci (2009) 0.82
Elecsys hepatitis B surface antigen quantitative assay: performance evaluation and correlation with hepatitis B virus DNA during 96 weeks of follow-up in chronic hepatitis B patients. Ann Lab Med (2012) 0.79
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B. Clin Mol Hepatol (2014) 0.77
Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Correlation between HBsAg quantitation and HBV DNA in HBeAg-negative HBV/D patients. Saudi J Gastroenterol (2013) 0.75
Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med (1999) 5.32
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med (1990) 4.53
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med (1993) 3.53
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet (2005) 3.33
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology (1982) 2.74
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol (2007) 1.85
Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods (2004) 1.49
Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol (2006) 1.22
Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol (2004) 1.03
Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol (2006) 0.96
New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology (2003) 0.94
Serologic and molecular diagnosis of hepatitis B virus. Clin Liver Dis (2004) 0.84
Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers. J Med Virol (2005) 0.84
HBV virological assessment. J Hepatol (2005) 0.83
Serological and molecular diagnosis. Semin Liver Dis (2006) 0.83
Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. J Med Virol (2007) 0.81
Research methodology. Part IV: Understanding canonical correlation analysis. ABNF J (1996) 0.75
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet (2005) 3.33
Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect (2009) 2.30
A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection. Wien Klin Wochenschr (2013) 2.20
Sexual transmission of HCV between spouses. Am J Gastroenterol (2005) 2.08
Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? Biomark Med (2010) 2.05
Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study). Hepatology (2015) 1.74
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology (2008) 1.56
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. Am J Gastroenterol (2010) 1.54
Levofloxacin-induced delirium. Clin Neurol Neurosurg (2005) 1.50
Sertraline hepatotoxicity: report of a case and review of the literature. Dig Dis Sci (2008) 1.49
Impact of day versus night as intervention time on the outcomes of primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv (2009) 1.48
Acute renal failure due to crush syndrome during Marmara earthquake. Am J Kidney Dis (2002) 1.47
Neutrophilic pleocytosis in cerebrospinal fluid: adult-onset Still's disease. Intern Med (2003) 1.46
Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir. Turk J Gastroenterol (2015) 1.45
The role of antibiotic treatment alone for the management of Brucella endocarditis in adults: a case report and literature review. Ann Thorac Cardiovasc Surg (2002) 1.39
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels. Hepatology (2010) 1.34
The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis (2009) 1.33
Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail (2006) 1.29
Typhoid fever as a rare cause of hepatic, splenic, and bone marrow granulomas. Intern Med (2004) 1.25
The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field survey. BMC Infect Dis (2009) 1.25
Acute viral cholecystitis due to hepatitis A virus infection. J Clin Gastroenterol (2003) 1.25
Association of secondary amyloidosis with common variable immune deficiency and tuberculosis. Yonsei Med J (2005) 1.17
Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant (2011) 1.16
Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels (2008) 1.11
Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J Antimicrob Chemother (2004) 1.10
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a. J Hepatol (2012) 1.10
The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol (2004) 1.09
Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother (2014) 1.09
Localized hepatic tuberculosis. Eur J Intern Med (2003) 1.09
Acute pancreatitis associated with the use of peginterferon. Pancreas (2007) 1.09
Tuberculous, brucellar and pyogenic spondylitis: comparison of magnetic resonance imaging findings and assessment of its value. South Med J (2007) 1.05
Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis (2007) 1.04
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology (2014) 1.04
Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology (2008) 1.02
Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis (2007) 1.02
Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig Dis Sci (2007) 1.00
Abducent nerve palsy during treatment of brucellosis. Clin Neurol Neurosurg (2003) 1.00
A meningitis case due to Stenotrophomonas maltophilia and review of the literature. Int J Infect Dis (2008) 1.00
Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99
Colistin nephrotoxicity increases with age. Scand J Infect Dis (2014) 0.99
Erythema nodosum: an experience of 10 years. Scand J Infect Dis (2004) 0.99
Aspergillus fumigatus infection as a delayed manifestation of prosthetic knee arthroplasty and a review of the literature. Scand J Infect Dis (2011) 0.96
Vertebral osteomyelitis: eight years' experience of 100 cases. Rheumatol Int (2011) 0.96
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B. Hepatology (2012) 0.96
Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm. Int J Antimicrob Agents (2012) 0.96
Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. J Hepatol (2007) 0.96
Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res (2004) 0.95
Abiotrophia defectiva: a rare cause of infective endocarditis. Scand J Infect Dis (2006) 0.94
Fascioliasis: 3 cases with three different clinical presentations. Turk J Gastroenterol (2012) 0.94
N-acetylcysteine attenuates alcohol-induced oxidative stress in the rat. World J Gastroenterol (2003) 0.93
Acute hepatitis C: prevention and treatment. Expert Rev Anti Infect Ther (2009) 0.93
Losartan-induced hepatic injury. J Clin Gastroenterol (2002) 0.93
The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats. Dig Dis Sci (2007) 0.92
New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res (2013) 0.92
Isolation of amniotic mesenchymal stem cells. Curr Protoc Stem Cell Biol (2010) 0.92
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turk J Gastroenterol (2012) 0.92
Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats. Can J Surg (2010) 0.92
Prevalence of hepatic granulomas in chronic hepatitis B. Dig Dis Sci (2004) 0.91
The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis (2003) 0.91
Prospective observational study on antibiotic-associated bloody diarrhea: report of 21 cases with a long-term follow-up from Turkey. Eur J Gastroenterol Hepatol (2012) 0.91
Improved sensitivity of nucleic acid amplification for rapid diagnosis of tuberculous meningitis. J Clin Microbiol (2004) 0.91
Effects of carvacrol on defects of ischemia-reperfusion in the rat liver. Phytomedicine (2008) 0.91
Vitamin E has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg (2011) 0.90
Autoimmune hepatitis induced by the prolonged hepatitis A virus infection. Ann Hepatol (2008) 0.89
Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology (2013) 0.89
Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats. J Pineal Res (2009) 0.89
Predictive factors for occupational bloodborne exposure in Turkish hospitals. Am J Infect Control (2008) 0.89
Hydatid cyst of the lesser sac. Intern Med (2007) 0.89
Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. J Crohns Colitis (2010) 0.89